Weinberger Asset Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$215K Buy
+855
New +$184K 0.07% 97
2026
Q1
Sell
-1,024
Closed -$234K 93
2025
Q4
$234K Buy
1,024
+18
+2% +$4.1K 0.08% 88
2025
Q3
$233K Buy
+1,006
New +$205K 0.08% 82
2025
Q2
Sell
-1,001
Closed -$210K 82
2025
Q1
$210K Buy
+1,001
New +$195K 0.09% 79

Other funds holding ABBV

Weinberger Asset Management's ABBV Position: Q2 2026 in Review

Weinberger Asset Management opened a new position in AbbVie (ABBV) in Q2 2026: 855 shares worth $215K. The stake represents 0.07% of the portfolio and ranks #97 among its holdings. This is a return to the name: Weinberger Asset Management previously reported a position in ABBV as recently as Q4 2025.

Weinberger Asset Management first reported a position in ABBV in Q1 2025 and has held it in 4 quarters since. The position peaked at $234K in Q4 2025. 4,187 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Weinberger Asset Management held 855 shares of AbbVie worth $215K as of Q2 2026.
  • AbbVie was a new Weinberger Asset Management position in Q2 2026.
  • AbbVie made up 0.07% of Weinberger Asset Management's portfolio in Q2 2026, its #97 holding.
  • Weinberger Asset Management first reported a position in AbbVie in Q1 2025 and has held it in 4 quarters since.
  • Weinberger Asset Management's AbbVie position peaked at $234K in Q4 2025.
  • 4,187 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Weinberger Asset Management's 13F filing for Q2 2026, filed 5 Aug 2026.